Search Articles — Sudonull

Search Results

In this project

IPO Conexeu Sciences: Nasdaq and tissue regeneration technology

https://sudonull.com/ipo-conexeu-sciences-nasdaq-and-tissue-regeneration-technology

Conexeu Sciences went public on Nasdaq with no revenue but with 3D-bioprinting of breast matrix. Risk analysis, regulatory contradictions, and 90-day forecast. Read.

From other projects

Biotechnologies in cosmetology: exosomes and peptides

https://ymaho.com/biotechnologies-in-cosmetology-exosomes-and-peptides

How exosomes and peptides replace hyaluronic acid in aesthetic medicine. Learn about real breakthroughs and marketing myths in skin regeneration. Read the review.

Stem cell kidney growth implant: trials in Japan

https://ymaho.com/stem-cell-kidney-growth-implant-trials-in-japan

Trials of an implant for growing kidneys from stem cells have begun in Japan. The technology could replace dialysis. Details about the breakthrough and risks — in the analysis.

RNA editing with light: CRISPR/Cas13d for deep tissues

https://ymaho.com/rna-editing-with-light-crispr-cas13d-for-deep-tissues

Scientists created a photoactivatable system paCas13d with nanoparticles. The technology cured bone necrosis in mice without harming systemic therapy. Learn how IR light controls genes at tissue depth.

Exosomes and NAD+ in Home Care: The Rejuvenation Crisis

https://ymaho.com/exosomes-and-nad-in-home-care-the-rejuvenation-crisis

We analyze why exosomes and NAD+ in cosmetics are not a breakthrough but a crisis of legitimacy. Learn about the risks, instability, and hidden problems of the market. Read the analysis!

Blood cells created from stem cells in the laboratory

https://ymaho.com/blood-cells-created-from-stem-cells-in-the-laboratory

Australian scientists have for the first time obtained hematopoietic stem cells in vitro. The technology promises to replace bone marrow transplantation and genetically correct blood cells. A breakthrough in hematology.

Heart Bioprinting: Harvard's Breakthrough in Creating Blood Vessels

https://ymaho.com/heart-bioprinting-harvard-s-breakthrough-in-creating-blood-vessels

Harvard scientists printed heart tissue with blood vessels that integrated in rats within 7 days. Details of Co-SWIFT technology, AI, and prospects for cardiac surgery. Read the analysis.

Regenerative care instead of anti-aging cosmetics: trend 2026

https://ymaho.com/regenerative-care-instead-of-anti-aging-cosmetics-trend-2026

Exosomes and peptides are displacing anti-wrinkle creams. Find out why regenerative aesthetics is growing by 13% per year and who is making billions. Read the analysis.

Pharma-biotics: PDRN and exosomes in K-Beauty 2026

https://ymaho.com/pharma-biotics-pdrn-and-exosomes-in-k-beauty-2026

Analysis of the PDRN and exosome boom in Korea: why mass brands are losing, prices 6-10 times lower than procedures, risks and forecasts. Read about the revolution of regenerative care.

NeoHelix Regenerate: BASF peptide for adaptive collagen

https://ymaho.com/neohelix-regenerate-basf-peptide-for-adaptive-collagen

BASF introduced the NeoHelix Regenerate peptide for targeted collagen repair. Learn how CHP technology is changing anti-aging care and the ingredient market. Read the analysis!

Optic nerve regeneration: gene therapy and stimulation

https://ymaho.com/optic-nerve-regeneration-gene-therapy-and-stimulation

Nature breakthrough: optic nerve regeneration in mice using gene therapy and visual stimulation. Analysis of implications for glaucoma treatment and the market. Learn more.

Trending Now